AwardTape · Defense awards · Medical · Drugs and biologicals · SPE2D326F6771
SPE2D326F6771: $170 delivery order to Hikma Pharmaceuticals USA Inc
Hikma Pharmaceuticals USA Inc holds a delivery order from Defense Logistics Agency with $170 obligated since Oct 2023, against a ceiling of $170. Latest action Feb 27, 2026.
4570983245 ondansetron hcl 4 mg/2 ml vial 2ml
| PIID | SPE2D326F6771 |
|---|---|
| Type | delivery order |
| Parent award | SPE2D020D0006 |
| Company | Hikma Pharmaceuticals USA Inc |
| Agency | Defense Logistics Agency |
| Contracting office | DLA TROOP SUPPORT |
| Category | Medical · Drugs and biologicals |
| PSC | 6505 DRUGS AND BIOLOGICALS |
| NAICS | 325411 MEDICINAL AND BOTANICAL MANUFACTURING |
| Obligated since Oct 2023 | $170 |
| Total obligated (lifetime) | $170 |
| Ceiling (base and all options) | $170 |
| Base date | Feb 27, 2026 |
| Latest action | Feb 27, 2026 |
| End date | Mar 2, 2026 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Full and open competition |
| Place of performance | NJ |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial